Cargando…
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis
BACKGROUND: There are no approved noninvasive tests (NIT) for the diagnosis of nonalcoholic steatohepatitis (NASH) and its histological phenotypes. METHODS: The FNIH-NIMBLE consortium tested 5 serum-based NIT panels for the following intended uses: NIS4: At-risk NASH, a composite of NASH with NAFLD...
Autores principales: | Sanyal, Arun, Shankar, Sudha, Yates, Katherine, Bolognese, James, Daly, Erica, Dehn, Clayton, Neuschwander-Tetri, Brent, Kowdley, Kris, Vuppalanchi, Raj, Behling, Cynthia A., Tonascia, James, Samir, Anthony, Sirlin, Claude, Sherlock, Sarah, Fowler, Kathryn, Heymann, Helen, Kamphaus, Tania, Loomba, Rohit, Calle, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882658/ https://www.ncbi.nlm.nih.gov/pubmed/36711803 http://dx.doi.org/10.21203/rs.3.rs-2492725/v1 |
Ejemplares similares
-
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2023) -
Validation of the accuracy of the FAST(™) score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
por: Woreta, Tinsay A., et al.
Publicado: (2022) -
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance
por: Gill, Ryan M., et al.
Publicado: (2023) -
The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020) -
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)